In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.

We tested CI-919 (AT-2266), a nalidixic acid analog, against 555 gram-positive and gram-negative bacteria, using microbroth or agar dilution methods. The activity of CI-919 was compared with those of cephalosporins, tobramycin, ticarcillin, dicloxacillin, rifampin, chloramphenicol, ampicillin, and t...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Chartrand, S A, Scribner, R K, Weber, A H, Welch, D F, Marks, M I
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1983
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC184783/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6223577/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.23.5.658
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!